PL2085389T3 - Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową - Google Patents

Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową

Info

Publication number: PL2085389T3
Authority: PL; Poland
Prior art keywords: phenyl; substituted; substituents; ester; lower alkyl
Prior art date: 2006-11-14

Application number

PL07831813T

Other languages

English (en)

Inventor

Mamoru Matsuda

Masato Nagatsuka

Toshiyuki Mori

Sachiko Kobayashi

Masatomo Kato

Miwa Takai

Original Assignee

Santen Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-14

Filing date

2007-11-14

Publication date

2013-02-28

2007-11-14 Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd

2013-02-28 Publication of PL2085389T3 publication Critical patent/PL2085389T3/pl

Links

125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 2
IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical class C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 title 1
125000005907 alkyl ester group Chemical group 0.000 title 1
125000000217 alkyl group Chemical group 0.000 title 1
125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 title 1
125000000623 heterocyclic group Chemical group 0.000 title 1
125000001424 substituent group Chemical group 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Addiction (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Transplantation (AREA)

PL07831813T 2006-11-14 2007-11-14 Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową PL2085389T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2006307651		2006-11-14
PCT/JP2007/072083 WO2008059867A1 (en)	2006-11-14	2007-11-14	Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
EP07831813A EP2085389B1 (en)	2006-11-14	2007-11-14	1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents

Publications (1)

Publication Number	Publication Date
PL2085389T3 true PL2085389T3 (pl)	2013-02-28

Family

ID=39401671

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL07831811T PL2085387T3 (pl)	2006-11-14	2007-11-14	Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową
PL07831812T PL2085388T3 (pl)	2006-11-14	2007-11-14	Nowa pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki podstawioną grupę fenyloamino-niższą alkilową oraz wprowadzoną przez ester grupę fenylową
PL07831813T PL2085389T3 (pl)	2006-11-14	2007-11-14	Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PL07831811T PL2085387T3 (pl)	2006-11-14	2007-11-14	Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową
PL07831812T PL2085388T3 (pl)	2006-11-14	2007-11-14	Nowa pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki podstawioną grupę fenyloamino-niższą alkilową oraz wprowadzoną przez ester grupę fenylową

Country Status (12)

Country	Link
US (6)	US8008496B2 (pl)
EP (3)	EP2085389B1 (pl)
JP (3)	JP4817020B2 (pl)
KR (3)	KR20090086070A (pl)
CN (4)	CN101535266A (pl)
CA (3)	CA2668592C (pl)
ES (3)	ES2416289T3 (pl)
HK (1)	HK1208868A1 (pl)
NO (1)	NO342905B1 (pl)
PL (3)	PL2085387T3 (pl)
RU (1)	RU2485104C2 (pl)
WO (3)	WO2008059866A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2455142T3 (es) *	2005-09-14	2014-04-14	Santen Pharmaceutical Co., Ltd.	Nuevo derivado de 1-2-dihidroquinolina que tiene actividad de unión al receptor de glucocorticoides
EP1995242B1 (en)	2006-03-14	2012-11-07	Santen Pharmaceutical Co., Ltd	Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
US8008496B2 (en) *	2006-11-14	2011-08-30	Santen Pharmaceutical Co., Ltd.	1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
ES2419239T3 (es)	2007-05-29	2013-08-20	Santen Pharmaceutical Co., Ltd	Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene como sustituyente un grupo fenilo con una estructura de éster de ácido sulfónico o una estructura de amida de ácido sulfónico introducida en el mismo y que tienen una actividad de unión al receptor de glucocorticoides
KR20110010634A (ko) *	2008-05-12	2011-02-01	산텐 세이야꾸 가부시키가이샤	치환 옥시기를 가지는 2,2,4-트리메틸-6-페닐-1,2-디하이드로퀴놀린 유도체를 포함하는 글루코코르티코이드 수용체 작용제
WO2010029986A1 (ja) *	2008-09-12	2010-03-18	参天製薬株式会社	スルホン酸エステル構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体からなるグルココルチコイド受容体アゴニスト
KR101268725B1 (ko)	2008-09-30	2013-05-28	히타치가세이가부시끼가이샤	코트제, 이것을 사용한 광반도체 소자 탑재용 기판 및 광반도체 장치
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de)	2010-06-18	2011-12-22	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012108455A1 (ja)	2011-02-09	2012-08-16	参天製薬株式会社	３－ヒドロキシ－６Ｈ－ベンゾ［ｃ］クロメン－６－オン誘導体およびその製造方法
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR20140117481A (ko)	2012-01-20	2014-10-07	산텐 세이야꾸 가부시키가이샤	1,2-디하이드로퀴놀린 유도체 또는 그의 염의 공업적 제조 방법 및 그 제조 중간체
KR20150000874A (ko)	2012-01-31	2015-01-05	산텐 세이야꾸 가부시키가이샤	비수성 액체 조성물
JP2014139161A (ja) *	2012-12-20	2014-07-31	Santen Pharmaceut Co Ltd	１，２−ジヒドロキノリン合成中間体の製造方法
TW201609145A (zh)	2013-12-25	2016-03-16	參天製藥股份有限公司	注射劑及形成緩釋（ｄｅｐｏｔ）之方法
US20200121652A1 (en)	2017-06-16	2020-04-23	The Doshisha	Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent
EP3639854B1 (en)	2017-06-16	2026-01-07	The Doshisha	Mtor-inhibitor-containing medicine for treating or preventing fuchs' endothelial corneal dystrophy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6696459B1 (en)	1994-12-22	2004-02-24	Ligand Pharmaceuticals Inc.	Steroid receptor modulator compounds and methods
EP1043325B1 (en)	1994-12-22	2004-06-16	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US5696127A (en)	1994-12-22	1997-12-09	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US6372073B1 (en) *	1999-08-11	2002-04-16	Southpac Trust International Inc.	Process for producing holographic material
CN1703403A (zh) *	2000-10-02	2005-11-30	詹森药业有限公司	趋代谢的谷氨酸盐受体拮抗剂
DE60113032T2 (de) *	2000-10-30	2006-07-06	Pfizer Products Inc., Groton	Glukokortikoidrezeptor-Modulatoren
US7638630B2 (en)	2002-04-30	2009-12-29	Ucb Pharma S.A.	2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
CA2496175A1 (en) *	2002-08-21	2004-03-04	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7135575B2 (en) *	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
BRPI0513119A (pt)	2004-07-14	2008-04-29	Ligand Pharm Inc	compostos e métodos modulares de receptores intracelulares
JP4825636B2 (ja) *	2005-09-14	2011-11-30	参天製薬株式会社	グルココルチコイド受容体結合活性を有する新規１，２−ジヒドロキノリン誘導体
ES2455142T3 (es) *	2005-09-14	2014-04-14	Santen Pharmaceutical Co., Ltd.	Nuevo derivado de 1-2-dihidroquinolina que tiene actividad de unión al receptor de glucocorticoides
US8008496B2 (en)	2006-11-14	2011-08-30	Santen Pharmaceutical Co., Ltd.	1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
JP2008255112A (ja)	2007-03-13	2008-10-23	Santen Pharmaceut Co Ltd	２，２，４−トリメチル−６−フェニル−１，２−ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト
EP2249730A1 (en) *	2008-03-06	2010-11-17	Synthes GmbH	Facet interference screw
KR20110010634A (ko) *	2008-05-12	2011-02-01	산텐 세이야꾸 가부시키가이샤	치환 옥시기를 가지는 2,2,4-트리메틸-6-페닐-1,2-디하이드로퀴놀린 유도체를 포함하는 글루코코르티코이드 수용체 작용제

2007
- 2007-11-14 US US12/312,392 patent/US8008496B2/en active Active
- 2007-11-14 CN CNA2007800420010A patent/CN101535266A/zh active Pending
- 2007-11-14 EP EP07831813A patent/EP2085389B1/en not_active Not-in-force
- 2007-11-14 JP JP2007295227A patent/JP4817020B2/ja not_active Expired - Fee Related
- 2007-11-14 CN CNA2007800421193A patent/CN101605762A/zh active Pending
- 2007-11-14 EP EP07831812A patent/EP2085388B1/en not_active Not-in-force
- 2007-11-14 WO PCT/JP2007/072082 patent/WO2008059866A1/ja not_active Ceased
- 2007-11-14 US US12/312,393 patent/US8008497B2/en not_active Expired - Fee Related
- 2007-11-14 ES ES07831811T patent/ES2416289T3/es active Active
- 2007-11-14 ES ES07831812T patent/ES2391865T3/es active Active
- 2007-11-14 PL PL07831811T patent/PL2085387T3/pl unknown
- 2007-11-14 KR KR1020097009350A patent/KR20090086070A/ko not_active Ceased
- 2007-11-14 JP JP2007295256A patent/JP4969417B2/ja not_active Expired - Fee Related
- 2007-11-14 CN CN201510012203.7A patent/CN104672130A/zh active Pending
- 2007-11-14 ES ES07831813T patent/ES2391910T3/es active Active
- 2007-11-14 CN CNA2007800420839A patent/CN101535267A/zh active Pending
- 2007-11-14 CA CA2668592A patent/CA2668592C/en active Active
- 2007-11-14 CA CA002668596A patent/CA2668596A1/en not_active Abandoned
- 2007-11-14 WO PCT/JP2007/072083 patent/WO2008059867A1/ja not_active Ceased
- 2007-11-14 KR KR1020097009349A patent/KR101475534B1/ko not_active Expired - Fee Related
- 2007-11-14 PL PL07831812T patent/PL2085388T3/pl unknown
- 2007-11-14 JP JP2007295239A patent/JP4898635B2/ja not_active Expired - Fee Related
- 2007-11-14 CA CA002669607A patent/CA2669607A1/en not_active Abandoned
- 2007-11-14 WO PCT/JP2007/072081 patent/WO2008059865A1/ja not_active Ceased
- 2007-11-14 RU RU2009122375/04A patent/RU2485104C2/ru active
- 2007-11-14 EP EP07831811.0A patent/EP2085387B1/en active Active
- 2007-11-14 KR KR1020097009351A patent/KR20090086539A/ko not_active Ceased
- 2007-11-14 PL PL07831813T patent/PL2085389T3/pl unknown
- 2007-11-14 US US12/312,396 patent/US8008498B2/en not_active Expired - Fee Related
2009
- 2009-05-28 NO NO20092104A patent/NO342905B1/no unknown
2011
- 2011-06-30 US US13/135,256 patent/US8563551B2/en not_active Expired - Fee Related
- 2011-07-14 US US13/135,765 patent/US8580784B2/en not_active Expired - Fee Related
- 2011-07-14 US US13/135,790 patent/US8440660B2/en not_active Expired - Fee Related
2015
- 2015-09-30 HK HK15109650.5A patent/HK1208868A1/xx unknown

Also Published As

Publication number	Publication date
US20090298826A1 (en)	2009-12-03
JP2008143890A (ja)	2008-06-26
US20090298827A1 (en)	2009-12-03
EP2085388B1 (en)	2012-09-05
WO2008059865A1 (en)	2008-05-22
US8008496B2 (en)	2011-08-30
CN101605762A (zh)	2009-12-16
JP4898635B2 (ja)	2012-03-21
US20110263600A1 (en)	2011-10-27
EP2085387A4 (en)	2010-12-15
JP4969417B2 (ja)	2012-07-04
US8563551B2 (en)	2013-10-22
US20110275632A1 (en)	2011-11-10
EP2085387A1 (en)	2009-08-05
JP4817020B2 (ja)	2011-11-16
ES2391910T3 (es)	2012-12-03
US8008498B2 (en)	2011-08-30
RU2009122375A (ru)	2010-12-20
RU2485104C2 (ru)	2013-06-20
PL2085387T3 (pl)	2013-09-30
KR20090086070A (ko)	2009-08-10
CN101535267A (zh)	2009-09-16
JP2008143891A (ja)	2008-06-26
ES2391865T3 (es)	2012-11-30
CN104672130A (zh)	2015-06-03
NO20092104L (no)	2009-05-28
EP2085388A4 (en)	2010-12-15
US8580784B2 (en)	2013-11-12
WO2008059866A1 (en)	2008-05-22
NO342905B1 (no)	2018-08-27
KR101475534B1 (ko)	2014-12-22
HK1208868A1 (en)	2016-03-18
EP2085389A1 (en)	2009-08-05
US8008497B2 (en)	2011-08-30
CA2668592C (en)	2016-04-19
EP2085388A1 (en)	2009-08-05
KR20090086069A (ko)	2009-08-10
CA2668596A1 (en)	2008-05-22
KR20090086539A (ko)	2009-08-13
EP2085389B1 (en)	2012-09-26
US8440660B2 (en)	2013-05-14
EP2085387B1 (en)	2013-04-10
US20100056504A1 (en)	2010-03-04
EP2085389A4 (en)	2010-12-15
ES2416289T3 (es)	2013-07-31
CA2669607A1 (en)	2008-05-22
JP2008143889A (ja)	2008-06-26
US20110275620A1 (en)	2011-11-10
CN101535266A (zh)	2009-09-16
CA2668592A1 (en)	2008-05-22
PL2085388T3 (pl)	2013-01-31
WO2008059867A1 (en)	2008-05-22

Publication	Publication Date	Title
PL2085389T3 (pl)	2013-02-28	Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową
HUS1800017I1 (hu)	2018-05-28	Mikrobicidként alkalmazható heterociklusos amid származékok
PT2094263E (pt)	2014-01-13	Derivados da 2-adamantil-butiramida como inibidores seletivos da 11-beta-hsd1
ZA200710172B (en)	2008-11-26	Cyclic amine derivative having substituted alkyl group
ZA200804393B (en)	2009-04-29	Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors
ZA200709051B (en)	2008-10-29	Heterocyclic compound
PL1919907T3 (pl)	2011-07-29	Związek heterocykliczny
PL1937671T3 (pl)	2010-05-31	Związki benzimidazolotiofenowe jako inhibitory plk
IL189141A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
IL225653A0 (en)	2013-06-27	Homo- and hetero-cyclic compounds suitable as cetp inhibitors
IL187904A0 (en)	2008-03-20	Quinoline derivatives as antibacterial agents
ZA200709900B (en)	2009-03-25	Insecticidal substituted benzylamino heterocyclic and heteroaryl derivatives
IL189142A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
EP1879455A4 (en)	2011-12-28	INSECTICIDES SUBSTITUTED HETEROCYCLIC AMINOALKYL AND HETEROARYL DERIVATIVES
IL187575A0 (en)	2008-03-20	Benzofuranyl derivatives as 5-ht6-receptor inhibitors
IL189140A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
ZA200703835B (en)	2008-11-26	Heterocyclic substituted bisarylurea derivatives as kinase inhibitors
IL188393A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
IL188394A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
ZA200802087B (en)	2009-08-26	Benzimidazole thiophene compounds as PLK inhibitors
AP2547A (en)	2012-12-26	Quinoline derivatives as antibacterial agents
ZA200800142B (en)	2009-05-27	Heterocyclic compound
ZA200709428B (en)	2009-08-26	Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives